EHS
EHS

STAT3 isoforms: Alternative fates in cancer?

Related Articles

STAT3 isoforms: Alternative fates in cancer?

Cytokine. 2018 Jul 18;:

Authors: Aigner P, Just V, Stoiber D

Abstract
Signal transducer and activator of transcription (STAT) 3 is the main mediator of IL-6-type cytokine signaling and an important transcriptional regulator of cell proliferation, maturation and survival. It has been described as a key player in cancer development and progression. However, under certain circumstances, STAT3 is also considered a potent tumor suppressor. This heterogeneity partially depends on its expression as different isoforms. Alternative splicing gives rise to two STAT3 isoforms, STAT3α and its truncated version STAT3β. Both isoforms are transcriptionally active and display distinct functions under physiological and pathological conditions. In fact, while STAT3α is widely described as an oncogene, STAT3β has gained attention as a potential tumor suppressor. This review provides a concise overview of the current knowledge on STAT3 during tumorigenesis, with special emphasis on the unique and complex roles of its alternatively spliced isoforms.

PMID: 30031681 [PubMed – as supplied by publisher]

EHS
Back to top button